Press Kit

At Acclinate, our mission is to help pharmaceutical companies and healthcare organizations access and engage communities of color, so research is more inclusive. We are dedicated to transforming the landscape of healthcare, ensuring that every individual, regardless of their race, ethnicity, or socioeconomic background, has equal access and representation in clinical trials.

Our purpose is to bridge the gap between the healthcare industry and minority communities. By leveraging innovative approaches and cutting-edge technology, we empower these stakeholders to collaborate effectively, fostering trust and engagement within underserved populations.

Clinical trials serve as crucial investigations to assess the efficacy of new drugs and therapies. However, historically, these trials have predominantly involved white men as participants. It is imperative to recognize that individuals from various races, age groups, and genders often respond differently to medical treatments, due to inherent genetic disparities. Thus, to accurately measure the effectiveness of medical advancements, it’s imperative to advocate for comprehensive and representative inclusion in clinical research.

At Acclinate, we work tirelessly to foster strong relationships with communities of color, building a foundation of affective trust through our NOWINCLUDED platform. We actively listen, engage, and educate, empowering our communities with knowledge about the importance of inclusive clinical research and owning their individual health journey.